Filgrastim Injection

Filgrastim Injection

1097.0 INR/Pack

Product Details:

  • Pacakaging (Quantity Per Box) As per Brand/Manufacturer (commonly 1-5 vials/box)
  • Origin of Medicine Allopathic
  • Salt Composition Filgrastim
  • Dosage Form Injection
  • Indication Neutropenia, Cancer Chemotherapy-Induced Neutropenia, Bone Marrow Transplant
  • Drug Type Biological Product
  • Physical Form Other
  • Click to view more
X

Filgrastim Injection Price And Quantity

  • 1097.0 INR/Pack
  • 200 Pack

Filgrastim Injection Product Specifications

  • As per Brand/Manufacturer (commonly 1-5 vials/box)
  • Allopathic
  • Filgrastim
  • As Suggested
  • Biological Product
  • Cool And Dry Place
  • Doctor
  • Anti-Bacterial
  • Injection
  • Adults & Children (Under Prescription)
  • Neutropenia, Cancer Chemotherapy-Induced Neutropenia, Bone Marrow Transplant
  • Other
  • As Directed by Physician
  • 1 Vial/PFS per pack

Filgrastim Injection Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 5000 Pack Per Week
  • 1 Days
  • No
  • If order is confirmed we will reimburse the sample cost
  • North America, Asia, Australia, Central America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

1. Product Description

Grafeel Injection contains Pegfilgrastim, a long-acting granulocytecolony stimulating factor (GCSF). It is used to reduce the risk of neutropeniaa dangerously low white blood cell countin cancer patients undergoing cytotoxic chemotherapy. It works by promoting production of neutrophils in the bone marrow to strengthen the immune system and reduce infection risk .
We are recognized in the industry for providing Filgrastim Injection which is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. The offered injection is highly demanded in the market as it is utilized to treat neutropenia (low white blood cells) which is caused by cancer medicines. This Filgrastim Injection is processed under the supervision of our skilled professionals. Our injection is rigorously checked on different parameters to ensure purity and quality at the users end.


2. Technical Specifications

Dose

30 IU

Packaging Size

6x1 ml

Packaging Type

Box

Brand

Grafeel

Manufactured By

Dr. Reddys

Use

S.C./I.V Infusion


3. Product Highlights

  • Generic Name: Pegfilgrastim

  • Strength: 300g (sometimes labeled as 0.3mg)

  • Dosage Form: Injectable solution (pre-filled syringe)

  • Packaging Type: Prefilled single-use syringe in carton

  • Therapeutic Category: Hematopoietic growth factor GCSF

  • Application Area: Preventive therapy to boost neutrophils during chemotherapy

  • Formulation: Clear sterile solution, ready to inject

  • Storage Conditions:

    • Refrigerate at 28C (do not freeze)

    • Protect from light

    • Bring to room temperature before use

    • Discard unused portion as per regulations

  • Shelf Life: As specified by manufacturercheck packaging expiry

  • Regulatory Compliance: Manufactured in licensed and certified facilities under Indian regulatory standards


4. Therapeutic Uses

  • Prevention of febrile neutropenia following chemotherapy

  • Support during therapy for bone marrow transplantation or severe chronic neutropenia

  • Neutropenia management in HIV infection or prestem cell donation cases


5. Safety Profile & Side Effects

Common side effects:

  • Bone pain (frequently reported)

  • Weakness and fatigue

  • Headache

  • Rash or itching

  • Nausea, vomiting, diarrhea, constipation

  • Elevated blood uric acid or LDH levels

  • Oropharyngeal pain, hair loss, cough, breathing difficulty

  • Injection site reaction (redness, swelling, pain)

Serious risks (rare):

  • Splenic rupture, acute respiratory distress, allergic reactions

  • Leukocytosis or very high neutrophil counts (requires monitoring)

6. Precautions

  • Administer only under medical supervision not for self-injection.
  • Safety in pregnancy is not established; doctors evaluation required. Likely unsafe based on animal studies.
  • Probably safe during breastfeeding if prescribed by a physician
  • May cause fatigue affecting driving; avoid hazardous tasks if symptomatic.
  • No dose adjustment typically required in renal or liver impairment
  • Avoid co-administration with other medications causing high neutrophil counts without supervision.
  • Patients with pain from injection or bone discomfort have reported relief using painkillers like acetaminophen or ibuprofen, Claritin (antihistamine), warm showers, or changing injection sitealways consult with healthcare provider first


7. How It Works

Grafeel stimulates the bone marrow to increase neutrophil production following chemotherapy-induced depletion. By boosting white blood cell counts, it helps protect against serious infections when immunity is low.



Comprehensive Neutropenia Care

Filgrastim Injection is specifically formulated to manage neutropenia, a condition often arising during cancer chemotherapy or following bone marrow transplantation. By enhancing neutrophil counts in the body, it helps reduce the risk of infection and supports quicker recovery for immunocompromised patients.


Multiple Strengths and Forms

Available in two standard strengths (300 mcg/ml and 480 mcg/ml), Filgrastim caters to varied dosing requirements. Packaging includes both traditional vials and convenient prefilled syringes, ensuring ease of use and flexible administration options as per clinical needs.


Reliable and Safe Administration

Filgrastim Injection is administered subcutaneously or intravenously under the direction of a physician. Clear instructions and the guidance of healthcare professionals guarantee safe and efficient drug delivery, whether in a clinical setting or at home under supervision. Shelf life extends from 18 to 24 months, with storage advised in a cool and dry environment.

FAQs of Filgrastim Injection:


Q: How is Filgrastim Injection administered?

A: Filgrastim Injection can be given either subcutaneously (under the skin) or intravenously (into a vein), as directed by your physician. The method, dose, and frequency are determined by the treating doctor based on your specific medical condition.

Q: What conditions does Filgrastim treat?

A: Filgrastim is mainly used to treat neutropenia, especially when caused by cancer chemotherapy or bone marrow transplant procedures. It helps prevent infection by increasing the production of white blood cells.

Q: When should Filgrastim Injection be used?

A: Filgrastim is typically used when a patients white blood cell counts are critically low, such as after chemotherapy or a bone marrow transplant. The timing and duration depend on your doctors assessment and prescription.

Q: Where should Filgrastim Injection be stored?

A: Store Filgrastim Injection in a cool and dry place, away from direct sunlight and moisture. Always refer to the manufacturers label for specific storage instructions and keep the medication out of reach of children.

Q: What are the packaging options available for Filgrastim?

A: Filgrastim Injection is available in both single-use vials and prefilled syringes, commonly packed one unit per box, but some manufacturers may offer packs containing up to five units depending on clinical or institutional needs.

Q: What are the benefits of using Filgrastim Injection?

A: Filgrastim significantly reduces the risk of infections in patients with low white blood cell counts, allowing them to tolerate stronger cancer therapies and recover faster from immunosuppressive treatments.

Q: Who can use Filgrastim and is a prescription required?

A: Filgrastim is suitable for use in both adults and children, but only under the strict supervision of a qualified physician. This medication requires a medical prescription and is not intended for self-administration without professional guidance.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top